Detailseite
Projekt Druckansicht

Charakterisierung des antiviralen Immunfaktors CD317/tetherin

Fachliche Zuordnung Virologie
Förderung Förderung von 2010 bis 2019
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 163617427
 
Erstellungsjahr 2020

Zusammenfassung der Projektergebnisse

During the two funding periods the Fackler and Keppler laboratories thus far published a total of 11 papers in international journals, including Nature Medicine, PNAS and Cell Host Microbe with a focus on the restriction factor CD317/THN and its viral antagonist, Vpu. Basic insight was reached regarding Vpu’s mode of counteraction, essential motifs and trafficking machinery and its ability to affect in a very general way, similar to Nef, the surface proteome to optimize the infected cell’s environment for replication and virus egress. A screening approach identified a set of novel Vpu interactors the validation of which for CD317/THN antagonism and other Vpu functions is ongoing. As part of our extended restriction factor characterization, we established the micro-array-based tissue expression profiling for both CD317/THN and SAMHD1. Recent work also identified an unexpected role of SAMHD1 in chemoresistance of acute myeloid leukemia to specific nucleoside analogs. Collectively, this joint project advanced the fundamental insight into physiological HIV restriction factor expression patterns and modes of interference by the lentiviral Vpu protein.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung